Research has also revealed a correlation between higher cNfL levels and more CD4 + T cells, which have been linked to the inflammation observed in MS and the development of RRMS into SPMS (Sospedra and Martin, 2005; Salzer et al., 2010). This evidence concerns the gene CD4 and myeloid sarcoma.